PNC Financial Services Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-247
| Closed | -$22K | – | 4808 |
|
|
2021
Q4 | $22K | Buy |
247
+4
| +2% | +$264 | ﹤0.01% | 3517 |
|
|
2021
Q3 | $14K | Buy |
243
+232
| +2,109% | +$13.7K | ﹤0.01% | 3655 |
|
|
2021
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 4168 |
|
|
2021
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 4077 |
|
|
2020
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 3939 |
|
|
2020
Q3 | $1K | Sell |
11
-52
| -83% | -$3.47K | ﹤0.01% | 3898 |
|
|
2020
Q2 | $4K | Sell |
63
-2
| -3% | -$110 | ﹤0.01% | 3699 |
|
|
2020
Q1 | $3K | Sell |
65
-253
| -80% | -$11.6K | ﹤0.01% | 3706 |
|
|
2019
Q4 | $13K | Sell |
318
-32,939
| -99% | -$1.56M | ﹤0.01% | 3451 |
|
|
2019
Q3 | $1.52M | Buy |
+33,257
| New | +$1.87M | ﹤0.01% | 1089 |
|
|
2019
Q2 | – | Sell |
-79
| Closed | -$3K | – | 4194 |
|
|
2019
Q1 | $3K | Buy |
79
+29
| +58% | +$1.33K | ﹤0.01% | 3844 |
|
|
2018
Q4 | $2K | Sell |
50
-3
| -6% | -$118 | ﹤0.01% | 3892 |
|
|
2018
Q3 | $2K | Sell |
53
-174
| -77% | -$7.05K | ﹤0.01% | 3986 |
|
|
2018
Q2 | $10K | Sell |
227
-9,729
| -98% | -$418K | ﹤0.01% | 3697 |
|
|
2018
Q1 | $393K | Sell |
9,956
-1,104
| -10% | -$42.9K | ﹤0.01% | 1778 |
|
|
2017
Q4 | $376K | Sell |
11,060
-13,884
| -56% | -$396K | ﹤0.01% | 1810 |
|
|
2017
Q3 | $637K | Buy |
24,944
+24,744
| +12,372% | +$568K | ﹤0.01% | 1501 |
|
|
2017
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 3884 |
|
|
2017
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 3982 |
|
|
2016
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 3873 |
|
|
2016
Q3 | $4K | Sell |
200
-130
| -39% | -$2.16K | ﹤0.01% | 3729 |
|
|
2016
Q2 | $6K | Sell |
330
-5
| -1% | -$89 | ﹤0.01% | 3776 |
|
|
2016
Q1 | $7K | Buy |
335
+5
| +2% | +$80 | ﹤0.01% | 3719 |
|
|
2015
Q4 | $6K | Sell |
330
-180
| -35% | -$3.67K | ﹤0.01% | 3817 |
|
|
2015
Q3 | $9K | Sell |
510
-46
| -8% | -$1.56K | ﹤0.01% | 3731 |
|
|
2015
Q2 | $26K | Buy |
556
+58
| +12% | +$2.52K | ﹤0.01% | 3388 |
|
|
2015
Q1 | $22K | Buy |
498
+150
| +43% | +$6.97K | ﹤0.01% | 3466 |
|
|
2014
Q4 | $12K | Hold |
348
| – | – | ﹤0.01% | 3334 |
|
|
2014
Q3 | $15K | Sell |
348
-1,140
| -77% | -$50.9K | ﹤0.01% | 3161 |
|
|
2014
Q2 | $86K | Hold |
1,488
| – | – | ﹤0.01% | 2352 |
|
|
2014
Q1 | $94K | Sell |
1,488
-202
| -12% | -$13.4K | ﹤0.01% | 2243 |
|
|
2013
Q4 | $99K | Buy |
1,690
+100
| +6% | +$5.23K | ﹤0.01% | 2203 |
|
|
2013
Q3 | $83K | Buy |
1,590
+160
| +11% | +$10.7K | ﹤0.01% | 2265 |
|
|
2013
Q2 | $110K | Buy |
+1,430
| New | +$117K | ﹤0.01% | 2059 |
|
PNC Financial Services Group's ARNA Position: Q1 2022 in Review
PNC Financial Services Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 247 shares — an estimated $22K sold.
PNC Financial Services Group first reported a position in ARNA in Q2 2013 and held it in 34 quarters. The position peaked at $1.52M in Q3 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- PNC Financial Services Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- PNC Financial Services Group sold 247 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $22K.
- PNC Financial Services Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 34 quarters.
- PNC Financial Services Group's Arena Pharmaceuticals Inc position peaked at $1.52M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on PNC Financial Services Group's 13F filing for Q1 2022, filed 12 May 2022.